Clinical Study
ZYN002: A Study for Children and Adolescents with Fragile X Syndrome (FXS)
Fragile X Syndrome (FXS) is when a gene in a persons body stops making protein. This protein is needed for a persons brain development. ZYN002 is a gel put on the skin to help children and adolescents with FXS. Research is needed to learn more about the efficacy and safety of ZYN002. The information we gain may aid future patients.
For more information contact:
Carly Straley
Carly.Straley@hsc.utah.edu
801-587-3136
IRB#: IRB_00146490
| PI: Victoria Wilkins
| Department: PEDIATRIC INPATIENT MEDICINE
| Approval Date: 2022-01-20 07:00:00
Study Categories: Neurological Studies
| Specialties: Pediatric Neurology
Who can participate?
Gender: All
Age: Under 18 years old
Volunteers: Volunteers with special conditions
Location: In Person
Inclusion Criteria:
- Ages 3 to 17 years
- Diagnosed FXS
- Healthy FXS participants
- Agree to use birth control if applicable
- Attend in-person at the University of Utah
Exclusion Criteria:
- A severe or unstable disease
- History of heart disease
- Any skin disease
- Drug abuse the year before participation
Will I be paid for my time?
Yes